Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
July 4, 2007
Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics
Chris Bushe, Michael Shaw
The British Journal of Psychiatry. Supplement
|
April 2, 2004
Association between atypical antipsychotic agents and type 2 diabetes: review of prospective clinical data
Chris Bushe, Brian Leonard
The British Journal of Psychiatry. Supplement
|
April 2, 2004
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
Chris Bushe, Richard Holt
Journal of Psychopharmacology (Oxford, England)
|
November 11, 2005
The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
Chris Bushe, Carol Paton
Respiration; International Review of Thoracic Diseases
|
November 7, 2019
FeNO Variability When Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff
Chris Bushe, Alan Kamada, Rod Hafner
The British Journal of Psychiatry. Supplement
|
November 21, 2007
Measurement of long-term outcomes in observational and randomised controlled trials
Richard Hodgson, Chris Bushe, Robert Hunter
Journal of Psychopharmacology (Oxford, England)
|
August 3, 2012
Mortality in schizophrenia
Chris Bushe, Mark Taylor, Jari Haukka
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality
|
June 5, 2015
A systems approach to evaluating ionizing radiation: six focus areas to improve quality, efficiency, and patient safety
Jonathan B Perlin, Laura Mower, Chris Bushe
Journal of Psychopharmacology (Oxford, England)
|
August 16, 2008
A review of the association between antipsychotic use and hyperprolactinaemia
Chris Bushe, Michael Shaw, Robert C Peveler
Journal of Psychopharmacology (Oxford, England)
|
November 11, 2005
The role of lifestyle interventions and weight management in schizophrenia
Chris Bushe, Peter Haddad, Robert Peveler, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Psychopharmacology (Oxford, England)
|
July 4, 2007
Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics
Chris Bushe, Michael Shaw
The British Journal of Psychiatry. Supplement
|
April 2, 2004
Association between atypical antipsychotic agents and type 2 diabetes: review of prospective clinical data
Chris Bushe, Brian Leonard
The British Journal of Psychiatry. Supplement
|
April 2, 2004
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
Chris Bushe, Richard Holt
Journal of Psychopharmacology (Oxford, England)
|
November 11, 2005
The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
Chris Bushe, Carol Paton
Respiration; International Review of Thoracic Diseases
|
November 7, 2019
FeNO Variability When Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff
Chris Bushe, Alan Kamada, Rod Hafner
The British Journal of Psychiatry. Supplement
|
November 21, 2007
Measurement of long-term outcomes in observational and randomised controlled trials
Richard Hodgson, Chris Bushe, Robert Hunter
Journal of Psychopharmacology (Oxford, England)
|
August 3, 2012
Mortality in schizophrenia
Chris Bushe, Mark Taylor, Jari Haukka
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality
|
June 5, 2015
A systems approach to evaluating ionizing radiation: six focus areas to improve quality, efficiency, and patient safety
Jonathan B Perlin, Laura Mower, Chris Bushe
Journal of Psychopharmacology (Oxford, England)
|
August 16, 2008
A review of the association between antipsychotic use and hyperprolactinaemia
Chris Bushe, Michael Shaw, Robert C Peveler
Journal of Psychopharmacology (Oxford, England)
|
November 11, 2005
The role of lifestyle interventions and weight management in schizophrenia
Chris Bushe, Peter Haddad, Robert Peveler, et al.
Page
of 3